Overexpression of cyclin Y in non-small cell lung cancer is associated with cancer cell proliferation

被引：8

作者：

Yue WenTao ^{[1
]}

Zhao XiaoTing ^{[1
]}

Zhang LiNa ^{[1
]}

Liu ZhiDong ^{[2
]}

Ma Li ^{[1
]}

Jia WenYun ^{[1
]}

Qian Zhe ^{[1
]}

Zhang ChunYan ^{[1
]}

Wang Yue ^{[1
]}

Yang XueHui ^{[1
]}

Xu ShaoFa ^{[2
]}

机构：

[1] Capital Med Univ, Beijing Chest Hosp, Dept Cellular Biol, Beijing 101149, Peoples R China

[2] Capital Med Univ, Beijing Chest Hosp, Dept Thorac Surg, Beijing 101149, Peoples R China

来源：

SCIENCE CHINA-LIFE SCIENCES | 2010年 / 53卷 / 04期

关键词：

CCNY; NSCLC; lentivirus RNAi; H1299; EXPRESSION; A1;

D O I：

10.1007/s11427-010-0090-8

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Cyclin Y (CCNY) is a key cell cycle regulator that acts as a growth factor sensor to integrate extracellular signals with the cell cycle machinery. The expression status of CCNY in lung cancer and its clinical significance remain unknown. The data indicates that CCNY may be deregulated in non-small cell lung cancer, where it may act to promote cell proliferation. These studies suggest that CCNY may be a candidate biomarker of NSCLC and a possible therapeutic target for lung cancer treatment.

引用

页码：511 / 516

页数：6

共 50 条

[31] Non-small cell lung cancer
Hill, Andrew
Fisher, Patricia
Yeomanson, Dan
BRITISH MEDICAL JOURNAL, 2012, 345
[32] Non-small cell lung cancer
Besse, B.
Vignot, S.
ONCOLOGIE, 2013, 15 (7-8) : 371 - 376
[33] Non-small cell lung cancer
Nestle, U.
Hoffmann, H.
Reck, M.
Bruns, C.
ONKOLOGIE, 2022, 28 (12): : 1034 - 1037
[34] Non-small cell lung cancer
Sause, W
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 126 - 126
[35] Non-Small Cell Lung Cancer
Ettinger, David S.
Akerley, Wallace
Borghaei, Hossein
Chang, Andrew C.
Cheney, Richard T.
Chirieac, Lucian R.
D'Amico, Thomas A.
Demmy, Todd L.
Ganti, Apar Kishor P.
Govindan, Ramaswamy
Grannis, Frederic W., Jr.
Horn, Leora
Jahan, Thierry M.
Jahanzeb, Mohammad
Kessinger, Anne
Komaki, Ritsuko
Kong, Feng-Ming
Kris, Mark G.
Krug, Lee M.
Lennes, Inga T.
Loo, Billy W., Jr.
Martins, Renato
O'Malley, Janis
Osarogiagbon, Raymond U.
Otterson, Gregory A.
Patel, Jyoti D.
Pinder-Schenck, Mary C.
Pisters, Katherine M.
Reckamp, Karen
Riely, Gregory J.
Rohren, Eric
Swanson, Scott J.
Wood, Douglas E.
Yang, Stephen C.
Hughes, Miranda
Gregory, Kristina M.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2012, 10 (10): : 1236 - 1271
[36] Non-small cell lung cancer
M. Dediu
W. Hilbe
memo - Magazine of European Medical Oncology, 2008, 1 (4) : 247 - 251
[37] ;Non-small cell lung cancer
Dediu, M.
Hilbe, W.
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2008, 1 (04) : 247 - 251
[38] Non-small cell lung cancer
Adamietz, I. A.
Niederle, N.
ONKOLOGE, 2010, 16 (06): : 63 - 74
[39] OVEREXPRESSION OF LSD1 PROMOTE PROLIFERATION, MIGRATION AND INVASION IN NON-SMALL CELL LUNG CANCER
Lv, T.
Miao, X.
Lv, Y.
Zhan, P.
Shen, X.
Song, Y.
RESPIROLOGY, 2011, 16 : 163 - 163
[40] Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer
J S Keum
G Kong
S C Yang
D H Shin
S S Park
J H Lee
J D Lee
British Journal of Cancer, 1999, 81 : 127 - 132

← 1 2 3 4 5 →